李亞欣Ya-Hsin Li王哲恩Zhe-En Wang醫療產業科技管理學系2026-10-059999-12-3120202020-07-02https://handle.ncl.edu.tw/11296/2r2v57https://scholars.csmu.edu.tw/handle/123456789/20322目的:巴金森氏症與人類共存的年代十分久遠,伴隨現今的人口結構背景,巴金森氏症的醫療利用也隨之增加,本研究欲比較 2008 年有無巴金森氏症的兩種族群中,於不同人口學、醫療及健康因素下,其醫療利用和存活狀態之差別。方法:本研究資料來自衛生福利部衛生福利資料科學中心之健保資料庫之兩百萬人抽樣檔,研究對象為 2008 年巴金森氏症新確診個案為對象,利用傾向分數配對觀察巴金森氏症患者和無巴金森氏症患者。本研究使用 SAS 9.4 進行描述性統計和傾向分數配對,配對後利用次數分配和卡方檢定比較個人特質,再使用 T 檢定和 Anova 來比較兩族群人口學特質和健康因素在醫療次數和醫療費用上的差異,並利用複回歸探討個案在不同變項上與醫療利用的關係,最後使用存活分析探討個案在不同變項上的存活風險。結果:經由傾向分數配對後,巴金森氏症患者樣本共 856 人,無巴金森氏症患者樣本共 3424 人,以女性、低年齡人口學特徵者死亡風險較低,共病程度越嚴重者,其死亡風險相對提高,且醫療利用也較多,醫療密集度中高等族群,有較高的存活天數,但醫療密集度中等族群醫療利用較高,但死亡風險也較高。結論:年齡是影響有無巴金森氏症醫療利用及後續存活的重要因子,年齡越大,其死亡風險也越高,本研究發現性別、年齡、醫療密集度、共病程度及是否為巴金森氏症皆會影響巴金森氏症患者及無巴金森氏症患者之存活因素。Objective: Parkinson's disease has coexisted with humans for a longtime. With the current population structure background, the medical use ofParkinson's disease has also increased. This study wants to compare the twogroups with and without Parkinson's disease in 2008. Under differentdemographic, medical and health factors, the differences in medicalutilization and survival status. Methods: The data of this study are from the sample file of 2 millionpeople in the health insurance database of the Health and Welfare DataScience Center of the Ministry of Health and Welfare. The research object isthe newly diagnosed cases of Parkinson's disease in 2008. The tendencyscores are used to observe the case group and control group. This study usedSAS 9.4 for descriptive statistics and propensity score matching to comparethe differences in medical utilization and survival status between the twogroups. Results: After matching by propensity scores, there were a total of 856people in the case group and a total of 3424 people in the control group.Those with female and low-age demographic characteristics had a lower riskof death. The more severe the comorbidity, the higher the risk of death. Thereare also many medical uses. The high-medium ethnic groups with highmedical intensity have higher survival days, but the medium-ethnic ethnicgroups with high medical intensity have higher medical utilization, but therisk of death is also higher. Conclusion: Age is an important factor affecting the medical use andsubsequent survival of Parkinson’s disease. The older the age, the higher the risk of death. This study found that gender, age, medical intensity,comorbidity and whether it is Parkinson’s Both symptoms affect the survivalfactors of the Parkinson's disease case group and the control group.巴金森氏症傾向分數配對醫療利用存活因素Parkinson's diseasepropensity score matchingmedical utilizationsurvival status比較是否為巴金森氏患者其醫療利用與存活之差異thesis